AHL
TVGN icon

Abel Hall LLC’s Tevogen Bio Holdings TVGN Stock Holding History

Abel Hall LLC’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-271
Closed -$4.49K – 986
2025
Q4 		$4.49K Buy
271
+8
+3% +$208 ﹤0.01% 714
2025
Q3 		$10.3K Sell
263
-20
-7% -$984 ﹤0.01% 321
2025
Q2 		$17.7K Sell
283
-23
-8% -$1.31K 0.01% 271
2025
Q1 		$16.5K Sell
306
-61
-17% -$4.01K 0.01% 186
2024
Q4 		$18.9K Buy
+367
New +$23.9K 0.01% 158

Other funds holding TVGN

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Abel Hall LLC's TVGN Position: Q1 2026 in Review

Abel Hall LLC sold out of Tevogen Bio Holdings (TVGN) in Q1 2026, closing a stake of 271 shares — an estimated $4.49K sold.

Abel Hall LLC first reported a position in TVGN in Q4 2024 and held it in 5 quarters. The position peaked at $18.9K in Q4 2024. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

  • Abel Hall LLC reported no remaining Tevogen Bio Holdings position as of Q1 2026 after selling out during the quarter.
  • Abel Hall LLC sold 271 Tevogen Bio Holdings shares in Q1 2026, an estimated $4.49K.
  • Abel Hall LLC first reported a position in Tevogen Bio Holdings in Q4 2024 and held it in 5 quarters.
  • Abel Hall LLC's Tevogen Bio Holdings position peaked at $18.9K in Q4 2024.
  • 30 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.